Cargando…

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer

Emerging proof shows that abnormal lipometabolism affects invasion, metastasis, stemness and tumor microenvironment in carcinoma cells. However, molecular markers related to lipometabolism have not been further established in breast cancer. In addition, numerous studies have been conducted to screen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, She, Risheng, Zhu, Jianlin, Lu, Jin, Gao, Yuan, Song, Wenhua, Cai, Songwang, Wang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526348/ https://www.ncbi.nlm.nih.gov/pubmed/36182903 http://dx.doi.org/10.1186/s12885-022-10110-8

Ejemplares similares

Lipometabolism and Glycometabolism in Liver Diseases
por: Ding, Hao-ran, et al.
Publicado: (2018)

Neurodevelopmental trajectories, polygenic risk, and lipometabolism in vulnerability and resilience to schizophrenia
por: Duan, Jia, et al.
Publicado: (2023)

Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease
por: Dong, Jing, et al.
Publicado: (2017)

Effect of 24 h Fasting on Gene Expression of AMPK, Appetite Regulation Peptides and Lipometabolism Related Factors in the Hypothalamus of Broiler Chicks
por: Lei, Liu, et al.
Publicado: (2012)

A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma
por: Zhu, Jianlin, et al.
Publicado: (2023)

Microbial and metabolomic insights into the bovine lipometabolic responses of rumen and mammary gland to zymolytic small peptide supplementation
por: Liu, En, et al.
Publicado: (2022)

Untargeted Metabolomics Analysis Revealed Lipometabolic Disorders in Perirenal Adipose Tissue of Rabbits Subject to a High-Fat Diet
por: Xia, Siqi, et al.
Publicado: (2021)

Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
por: Gao, Wei, et al.
Publicado: (2012)

Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

Molecular networking-based lipid profiling and multi-omics approaches reveal new contributions of functional vanilloids to gut microbiota and lipometabolism changes
por: Hattori, Hiroyuki, et al.
Publicado: (2022)

Excessive Dietary Lipid Affecting Growth Performance, Feed Utilization, Lipid Deposition, and Hepatopancreas Lipometabolism of Large-Sized Common Carp (Cyprinus carpio)
por: Fan, Ze, et al.
Publicado: (2021)

Metagenomic insights into the modulatory effects of kelp powder (Thallus laminariae)-Treated dairy milk on growth performances and physiological lipometabolic processes of kunming mice
por: Xue, Fuguang, et al.
Publicado: (2022)

lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism
por: Wang, Luoluo, et al.
Publicado: (2022)

Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis
por: Song, Yao, et al.
Publicado: (2022)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
por: Liu, Jiazhou, et al.
Publicado: (2022)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
por: Chen, Ling, et al.
Publicado: (2023)

Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy
por: Zheng, Yushi, et al.
Publicado: (2023)

Novel technologies and emerging biomarkers for personalized cancer immunotherapy
por: Yuan, Jianda, et al.
Publicado: (2016)

The role of biomarkers in personalized immunotherapy
por: Sankar, Kamya, et al.
Publicado: (2022)

Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
por: Mei, Jie, et al.
Publicado: (2023)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
por: Zhang, Zhengfeng, et al.
Publicado: (2023)

FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction
por: Liu, Shuo, et al.
Publicado: (2020)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Ged, Yasser, et al.
Publicado: (2021)

Biomarkers in oral immunotherapy
por: ZHU, Haitao, et al.
Publicado: (2022)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
por: Zhu, Ying, et al.
Publicado: (2021)

DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
por: Liu, Nanbin, et al.
Publicado: (2023)

Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
por: Vafaizadeh, Vida, et al.
Publicado: (2020)

Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
por: Gandhi, Shipra
Publicado: (2023)

Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer
por: Mei, Jie, et al.
Publicado: (2022)

A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma
por: Yuan, Feng, et al.
Publicado: (2021)

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
por: Al-Mahayri, Zeina N., et al.
Publicado: (2020)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases
por: Wang, Lulu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j885stc09bgq6ehh4upvvfuaoi